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The high diversity of HLA binding preferences has been driven by the sequence diversity of short segments
of relevant pathogenic proteins presented by HLA molecules to the immune system. To identify possible
commonalities in HLA binding preferences, we quantify these using a novel measure termed “targeting
efﬁciency,” which captures the correlation between HLA-peptide binding afﬁnities and the conservation of the
targeted proteomic regions. Analysis of targeting efﬁciencies for 95 HLA class I alleles over thousands of
human proteins and 52 human viruses indicates that HLA molecules preferentially target conserved regions
in these proteomes, although the arboviral Flaviviridae are a notable exception where nonconserved regions are
preferentially targeted by most alleles. HLA-A alleles and several HLA-B alleles that have maintained close
sequence identity with chimpanzee homologues target conserved human proteins and DNA viruses such as
Herpesviridae and Adenoviridae most efﬁciently, while all HLA-B alleles studied efﬁciently target RNA viruses.
These patterns of host and pathogen specialization are both consistent with coevolutionary selection and
functionally relevant in speciﬁc cases; for example, preferential HLA targeting of conserved proteomic regions
is associated with improved outcomes in HIV infection and with protection against dengue hemorrhagic fever.
Efﬁciency analysis provides a novel perspective on the coevolutionary relationship between HLA class I
molecular diversity, self-derived peptides that shape T-cell immunity through ontogeny, and the broad range
of viruses that subsequently engage with the adaptive immune response.
Human leukocyte antigen (HLA) molecules and viruses are
thought to be locked in an evolutionary arms race, where
viruses adapt to evade HLA-restricted immune responses and
HLA alleles evolve to optimize the ﬁtness of human popula-
tions in the face of a wide range of pathogen species as well as
the genetic variation within each pathogenic species. HLA
diversity has been driven and maintained by heterozygote ad-
vantage (25), which is most evident in geographical regions
with greater pathogen diversity (51), and by frequency-depen-
dent selection, in which low-frequency allelic variants gain
advantage in an environment of shifting pathogen selection
(58). In turn, the selective pressures of HLA-restricted im-
mune responses on pathogens are evident in a range of im-
mune evasion strategies employed by viruses and encoded in
their genomes, such as the ability of large DNA viruses (e.g.,
herpesviruses) to “hide” by inhibiting antigen presentation
(61) and mimicking host peptides (39, 60) or the ability of
RNA viruses to “run” through rapid evolution of genetic di-
versity (22, 35, 40, 43, 52, 53).
We along with others have explored the rapid viral adapta-
tion to HLA-restricted immune responses using sequence
analyses and have detected statistically signiﬁcant associations
between host HLA alleles and speciﬁc amino acid polymor-
phisms of human immunodeﬁciency virus (HIV) and hepatitis
C virus (HCV) (4, 8, 28, 29, 43, 62). These ﬁndings have
informed and directed experimentation which has, for exam-
ple, conﬁrmed that some of these HLA allele-speciﬁc viral
polymorphisms are due to abrogation of HLA binding or pep-
tide processing (17, 28, 29, 34, 62). In contrast, there is a
paucity of direct evidence linking HLA evolution to the selec-
tive pressure of pathogens as the reproductive advantage for
humans operates on a long timescale (5). Limited direct evi-
dence from a set of 34 oncoproteins and HIV Nef suggests that
HLA alleles might preferentially target evolutionarily con-
served peptides (12, 23). As functionally important sites on
proteins tend to be evolutionarily conserved (12, 26, 64), im-
mune surveillance of conserved ligands focuses immune re-
sources to genomic areas in humans and pathogens where
mutations might alter function (26, 57) or incur a ﬁtness cost
(28, 29, 66).
The recent availability of large curated databases of genetic
* Corresponding author. Mailing address for S. Mallal: Institute for
Immunology and Infectious Diseases, Royal Perth Hospital and Mur-
doch University, Wellington Street, Murdoch 6150, Western Australia,
Australia. Phone: 61 8 9224 2899. Fax: 61 8 9224 2920. E-mail: S.Mallal
@iiid.com.au. Mailing address for N. Jojic: Microsoft Research, One
Microsoft Way, Redmond, WA 98052. Phone: (425) 497-8401. Fax:
(425) 936-7329. E-mail: jojic@microsoft.com.
§ Present address: Vaccine and Infectious Disease Division, Fred
Hutchinson Cancer Research Center, Seattle, WA 98109.
† Supplemental material for this article may be found at http://jvi
.asm.org/.
 Published ahead of print on 17 November 2010.
‡ The authors have paid a fee to allow immediate free access to this
article.
1310
 
o
n
 
A
p
r
i
l
 
2
4
,
 
2
0
1
3
 
b
y
 
S
U
B
 
N
O
.
6
3
7
4
5
2
9
1
h
t
t
p
:
/
/
j
v
i
.
a
s
m
.
o
r
g
/
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 sequences has aided in the investigation of evolutionary rela-
tionships between human and pathogen genetic diversity.
These databases enable studies of evolutionary conservation
using sequence variation (2). In addition, the experimental
determination of tens of thousands of HLA binding afﬁnity
measurements (48) has allowed robust estimation of binding
afﬁnities for a wide range of HLA-peptide combinations (38).
These data allow direct investigation into the relationship be-
tween HLA binding and target sequence conservation, as well
as into the differences in these patterns across viral species and
different HLA alleles.
Here, we examined the relationships between HLA class I
molecules and a large selection of pathogen-derived and self-
derived HLA peptide ligands, comparing the likelihood of a
given HLA molecule to bind a given peptide, and the relative
conservation of that peptide sequence (Fig. 1A). We term the
tendency of a given HLA molecule to bind to conserved re-
gions of a protein its “targeting efﬁciency.” Using this ap-
proach, we explored the variability of HLA alleles in their
ability to target conserved regions of human and viral proteins.
Finally, we explored the functional relevance of HLA targeting
efﬁciency and found that targeting efﬁciency is associated with
improved disease outcome for HIV infection and dengue virus
and accounts in part for interindividual variation in HIV viral
load in predictive models.
These ﬁndings suggest that the relationships between HLA
binding preference and evolutionary conservation of target
sequences provide a central basis around which balancing se-
lection of both host and pathogen genetic diversity may be
better understood, as ﬁrst proposed by Hughes and others (23,
64). Our interspecies approach is complementary to previous
intraspecies studies of HLA-allele speciﬁc viral polymorphisms
(27, 60, 63), which have more statistical power in the variable
than the conserved elements of pathogen genomes, and pro-
vides a novel tool with which HLA pathogen coevolution can
be examined.
MATERIALS AND METHODS
Conservation scores. Conservation scores for an analyzed protein were com-
puted using the ConSeq server (http://conseq.tau.ac.il/), which estimates the
conservation score C(i) for each protein site i using a phylogenetic tree built from
a set of homologous sequences. The tree is used to infer the evolutionary rates
(log probabilities of substitution) for each site along the given protein (2) (Fig.
1A). Conservation scores were computed only for proteins which had at least ﬁve
homologous proteins in the UniRef100 database (release 11.0). For computa-
tional efﬁciency, no more than 100 homologues were used. Homologous proteins
were aligned using the MUSCLE program, version 3.6. The site conservation
scores are computed in the context of the entire protein as ConSeq uses aligned
homologues to compute the phylogeny in which the targeted protein resides.
This analysis also incorporated adjustment for variables that may affect P values,
including various numbers of protein homologues in conservation score compu-
tations, as well as various protein length distributions. Comparisons of the effects
of using inter- versus intraspecies homologous proteins for estimating the evo-
lutionary rates are provided for HIV in Table S6 in the supplemental material.
FIG. 1. Computing allele efﬁciency scores. (A) A representative illustration of an MHC molecule (yellow) binding to a segment of the HIV-1
Gag protein, showing comparisons with the phylogenetically related simian immunodeﬁciency virus (SIV) Gag and feline immunodeﬁciency virus
(FIV) Gag proteins. While the topology of the phylogenetic tree is shared among the protein sites, the evolutionary rates, indicated by the variation
of color of the branches from red (most conserved) to blue (least conserved), may vary dramatically. (B and C) The allele targeting efﬁciency score
(r) for a given protein (herpesvirus-1 capsid triplex subunit 1 in this case) is deﬁned by the rank correlation coefﬁcient between site conservation
scores (evolutionary rate) and HLA site binding scores (an average binding energy for peptides containing the site), along the protein (HLA-
A*2402 here), assessed at each amino acid position. (D) Distributions of HLA-A and HLA-B locus efﬁciency scores for a range of human viruses.
Each point represents an HLA allele-speciﬁc efﬁciency for the relevant full-length viral proteome. Blue bars represent locus means. P values
indicate signiﬁcance of locus differences tested using mixed effects analysis (Fig. 5 and Table 1). Adeno, adenovirus; Flu, inﬂuenza virus; Hep B,
hepatitis B virus; HSV 2, herpes simplex virus type 1.
VOL. 85, 2011 HLA BINDING AND CONSERVATION OF TARGETED REGIONS 1311
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 Binding scores. The binding scores are based on experimental measurements
characterizing individual HLA-peptide interactions, as catalogued in the Im-
mune Epitope Database (IEDB) (48, 50), as well as known HLA-peptide binding
conﬁgurations (32). Binding energies of HLA-peptide complexes were system-
atically estimated using the adaptive double-threading (ADT) structure-based
approach (32) for estimating the binding energy of a major histocompatibility
complex (MHC)-peptide complex. The method estimates the 50% inhibitory
concentrations ([IC50s] a measure of the binding afﬁnity) after threading both
target peptides and HLA proteins (in particular, the known contact residues
shown in red on the HLA structure in Fig. 1A) onto solved HLA-peptide
complex structures. Here, we have focused on 9-mer peptide targets as the vast
majority of known HLA class I epitopes are of this length.
The model parameters were ﬁt to log IC50s obtained from the IEDB for
34,000 experiments covering 35 HLA-A and HLA-B alleles. We excluded all
HIV epitopes from these data for training in order to avoid a possible bias in the
analyses of HIV viral load data. The ADT model can provide estimates for HLA
molecules other than the limited number on which it was trained by threading the
arbitrary HLA sequence onto the structure of another similar HLA protein and
using the estimated model parameters, which generalize for the entire HLA
allelic family. We analyzed 95 HLA-A and HLA-B alleles from a Caucasian
population in Australia (43), a cohort which provided a total coverage of 95% of
HLA-A alleles and 90% of HLA-B alleles in Europe. We note that of these 95
alleles, empirical binding data were provided for only 35 alleles. Due to lack of
sufﬁcient experimental measurements for HLA-C alleles in the IEDB, we did not
consider these alleles in the current study. The binding score at a given position
along the protein is the sum of binding energies for nine overlapping peptides,
which measures the probability that the site will be visible to immune surveil-
lance. The binding energy model provides an energy estimate, Ea(e) 
Ea(e1,e2,…,e9), where a denotes the index of an HLA allele, and e is (e1,e2,…,e9)
the 9-mer peptide. The model is ﬁt to the logarithm of the IC50 measurements
for different allele-peptide combinations. Therefore, the probability of peptide
presentation is proportional to e
Ea(e), and high energy indicates low presenta-
tion probability and vice versa. In order to estimate the log probability of
presentation of a single site in a protein, presentation probabilities of all peptides
straddling that site need to be considered. As an estimate that is robust to
prediction errors, we deﬁne the binding score B(i) for the i-th amino acid in the
sequence s  (s1,s2,…,sN) of an arbitrary N-long protein whose segments may be
presented by an HLA molecule as follows: Bai
ji8
i Easj, sj1,... ,sj8. The
predicted binding energies are highly correlated with the true experimentally
measured binding energies (Spearman correlation of 0.75), and for some
alleles the accuracy of prediction for our method and for other prediction
methods (see, for example, references 3, 7, 16, 31, 44, 45, and 49) is believed to
be within the accuracy of the IC50 measurement error. A recent analysis of
various prediction methods can be found in Nielsen et al. (46).
Computing allele efﬁciency scores. The allele efﬁciency score r is deﬁned as the
Spearman correlation coefﬁcient of the binding score and the conservation score
for a given protein. A positive score indicates preferential targeting of conserved
regions, and a negative score indicates preferential targeting of variable regions.
Statistical analyses. Statistical comparisons were corrected for the potential
lack of independence of measurements resulting from the hierarchical structure
of the groups, such as correlations generated by similarities within viral families
and within HLA supertype classes. The sampling procedure for these analyses,
along with a detailed analysis of potential sources of bias in our analysis and a
detailed discussion of the statistical power of the methods used, is available in the
supplemental material.
Data sets. We obtained binding data for training the HLA binding predictor
from the IEDB resource, consisting of experimentally measured binding afﬁnities
(IC50s) for 34,000 HLA-peptide pairs, spanning 35 HLA-A and HLA-B alleles.
For the viral targeting analysis, we collected the sequences of the most commonly
studied human and plant viruses from the NCBI virus database. A full list is
provided in Table S2 in the supplemental material. NCBI GenBank accession
number information for individual viral proteins is available in Table S8 in the
supplemental material. We based our analysis of the human proteins with dis-
ease-associated mutations on a version of the Online Mendelian Inheritance in
Man (OMIM) database (McKusick-Nathans Institute of Genetic Medicine,
Johns Hopkins University, Baltimore, MD, and NCBI, National Library of Med-
icine, Bethesda, MD, as of February 2007 [http://www.ncbi.nlm.nih.gov/omim]).
A control group of randomly sampled proteins was obtained from the UniRef50
database, release 11.0 (http://www.pir.uniprot.org/search/textSearch_NR5.shtml),
which contains representatives of natural protein clusters with 50% interclass
similarity. The random sample did not include any human proteins. BLAST queries
were performed against the UniRef100 database.
HLA typing. A total of 200 Western Australian HIV Cohort participants
provided samples with consent for HLA typing. HLA class I genotyping was
resolved to the four-digit level based on the sequence of exon 2 and 3 (exon 2/3)
and using standard sequence-based typing (SBT). Allele and heterozygote am-
biguities between alleles not identical in exon 2/3 were resolved using alternative
primers.
Comparison of efﬁciency scores in human proteins and human and plant
viruses. In order to test the hypothesis that there is a correlation between
conservation and binding patterns in proteins known to interact with HLA
molecules, we examined the relationship between the efﬁciency scores of 95
HLA-A and HLA-B alleles (which account for more than 90% of all HLA alleles
in European Caucasians) for target proteins spanning 4,761 human proteins
derived from the OMIM database and 52 human viruses (see Table S2A in the
supplemental material). We also examined these same correlations in 70 plant
viruses (see Table S2B), as well as a control sample of 3,800 random proteins
obtained from the UniRef50 database expecting that we would observe signiﬁ-
cant, but weaker, efﬁciency scores because of the sharing of conservation patterns
between the proteins that typically do not interact with the immune system and
the human proteins and human viruses that do. These control groups were also
used to ascertain the signiﬁcance of targeting efﬁciencies and variations in tar-
geting efﬁciencies on human proteins and human viruses.
Additional analysis to detect potential bias. In order to verify that our con-
clusions were not dependent on the use of a speciﬁc predictor, we also used the
NetMHCpan online prediction method (3) to replicate our results on Gag
efﬁciency scores and HIV viral load correlations. Negative correlations with viral
load were also obtained using this method (data not shown). In addition, we also
conducted an analysis of HIV efﬁciency scores based on experimentally deter-
mined T-cell epitope maps and compared this analysis to the one obtained using
predicted epitope maps. We found more evidence for HLA targeting of con-
served regions when we used the measured epitope maps than when using the
predicted ones, indicating that our analysis may underestimate the extent of this
phenomenon (see supplemental material and Table S7).
RESULTS
Targeting efﬁciency. We introduce a novel score termed
“targeting efﬁciency” to quantify the relationship between
HLA binding and conservation of target peptides. The HLA
allele targeting efﬁciency score is deﬁned to be the Spearman
rank correlation coefﬁcient between binding scores and con-
servation scores for amino acids along a given protein. Positive
scores denote a preference for binding conserved regions while
negative scores indicated a preference to bind to variable re-
gions. The process of calculating a targeting efﬁciency score for
the example pair of the herpesvirus-1 capsid triplex subunit 1
protein and the HLA-A*2402 molecule is illustrated in Fig. 1B
and C. In addition to calculating targeting efﬁciency scores for
individual proteins, the approach also allowed an efﬁciency
score to be calculated for an entire proteome by concatenating
all protein sequences of the given pathogen for which data
were available.
HLA molecules preferentially target conserved areas of hu-
man proteins. In order to examine whether HLA molecules
preferentially target conserved targets on human proteins, we
analyzed a set of 4,761 proteins spanning the entire OMIM
database of human-disease associated proteins (http://www
.ncbi.nlm.nih.gov/omim/).This analysis showed that both
HLA-A and HLA-B molecules tend to preferentially bind to
conserved areas of human proteins (Fig. 2), as ﬁrst proposed
by Hughes and Hughes in 1995 in an analysis of 34 oncopro-
teins (23). These results are also in agreement with those
reported by Yeager et al. (64). The average targeting efﬁcien-
cies were signiﬁcantly higher for both HLA-A (P  10
76) and
HLA-B alleles (P  10
8) for OMIM proteins than for a
random sample of 3,800 proteins (UniRef50 database) (Fig. 3).
Similar targeting preferences were obtained from a smaller
1312 HERTZ ET AL. J. VIROL.
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 comparison using 300 randomly selected non-disease-related
human proteins and 300 randomly selected UniRef proteins
(see Table S3 in the supplemental material), verifying that this
property is not speciﬁc to disease-associated human proteins.
Importantly, the reported differences in efﬁciency distributions
are not a consequence of the differences in the raw scores of
the two parameters used to compute them as neither the bind-
ing scores (P  0.96) nor the conservation scores (P  0.99)
were distributed differently in human and UniRef random
protein sets. Additionally, signiﬁcantly higher binding scores
were observed at disease-associated mutation sites (P  10
10
over 2,825,558 sites), providing further evidence of HLA co-
evolution with its targets.
We were also interested in exploring the relationship be-
tween efﬁciency scores and the assignment of HLA alleles to
loci and to supertype groups (described in reference 29; see
also Table S1 in the supplemental material). Therefore, we
examined the efﬁciency scores of HLA-A versus HLA-B alleles
for both the human and random protein sets described above.
We found a marked preference for HLA-A to target conserved
regions of human proteins (HLA-A   HLA-B, P  10
300)
compared with the random UniRef50 sample (HLA-B 
HLA-A, P  0.00007). However, further analysis indicated
that while the distribution of efﬁciency scores appears more
uniformly positive for the HLA-A allele families (Fig. 4), a
limited number of HLA-B alleles also preferentially bind con-
served human protein sequences. For example, the B58 super-
type (e.g., HLA-B57 and -B58 alleles) and a subgroup of
HLA-B7 supertype alleles (HLA-B55 and -B56) have higher
efﬁciency scores than most other B alleles for human proteins
(Fig. 4). Interestingly, all of these alleles form a distinct HLA
cluster closely associated with chimpanzee Patr-B alleles (see
Fig. S2 in the supplemental material). Conversely, HLA-B
alleles from the B44, B27, and B7 supertype families (other
than B55 and B56) have low or negative average allele efﬁ-
ciencies for human proteins (Fig. 4). These results indicate that
grouping HLA alleles by their abilities to target conserved
regions of human proteins does not strictly follow their super-
type classiﬁcation, but it does reﬂect their phylogenetic history
as alleles that are more likely to target conserved areas of
human proteins cluster with chimpanzee Patr-B alleles (41).
Evolutionary conservation and HLA-viral interactions. To
determine if binding preferences for viruses follow a trend
similar to the one observed for human proteins, we computed
the HLA efﬁciency scores for 52 human viruses and 70 plant
viruses (listed in Tables S2A and S2B in the supplemental
material). Figure 5 (see also Fig. S3) shows the distribution of
efﬁciency scores as heat maps in which the viruses (x axis) are
grouped by their families, and the HLA allelic variants (y axis)
are organized into HLA supertype families characterized by
their HLA peptide binding preferences (56). Figure 1D also
presents the distribution of efﬁciency scores for HLA-A and
HLA-B alleles for a selection of human viruses. Importantly,
neither the binding scores (P  0.87) nor the conservation
scores (P  0.59) were distributed differently in the two viral
groups (human- and plant-infecting), consistent with previous
reports (30). However, differences emerge when allele target-
ing efﬁciency is considered, suggesting that the HLA system
has been optimized through coevolution with viruses to recog-
nize functionally important protein regions that are relevant to
pathogen threats. Most interestingly, these groupings revealed
patterns of efﬁciency variation over different HLA alleles and
different viral families (Fig. 5), indicating a possible functional
importance of the existence of long-lasting allelic lineages for
the HLA-A but not HLA-B allele locus (24, 41) and possible
evidence of specialization of the HLA loci. To assess this
further, we investigated the distribution of efﬁciency scores for
HLA-A and HLA-B loci according to viral genome composi-
tion and viral species, as described in the supplemental mate-
rial (22, 28, 29, 62).
HLA-A alleles preferentially target conserved regions of
DNA viruses. In our analysis of DNA viruses, we found that
both HLA-A and HLA-B loci demonstrated a preference for
targeting evolutionarily conserved regions of human DNA vi-
ruses relative to plant DNA virus species (P  0.01) (Fig. 6).
Moreover, there was also a striking general preference for
HLA-A alleles to target conserved regions of human DNA
viruses compared with HLA-B alleles (P  10
13). This was
most notable for the Herpesviridae and Adenoviridae (Table 1),
with signiﬁcant differences between HLA-A and HLA-B loci
for 8 of 10 viral proteomes assessed. Since these viruses have
emerged via distinct lineages through vertebrate evolution (13,
42), these observations are not readily explained by sequence
similarity between these viral families. Yet the results are con-
sistent with coevolutionary relationships between herpesvi-
ruses and adenoviruses and their human and ancestral primate
hosts (13). Moreover, we found a linear correlation between
FIG. 3. Mean efﬁciency scores of 4,761 human (OMIM) proteins
and 3,800 random (UniRef50) proteins. The P values are based on
mixed effects analysis (see the supplemental material).
FIG. 2. Comparative histograms of human and random protein
efﬁciency scores. These histograms demonstrate preferential targeting
of evolutionarily conserved self-peptides by class I HLA molecules.
The distribution of human efﬁciency scores is statistically signiﬁcantly
higher than that of random proteins (P  5.4 	 10
77).
VOL. 85, 2011 HLA BINDING AND CONSERVATION OF TARGETED REGIONS 1313
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 HLA allele efﬁciencies for the analyzed human proteins and
these DNA viruses (as shown for cytomegalovirus in Fig. 7A),
as well as strong correlations among overall efﬁciency scores
for the proteomes of DNA viruses (Fig. 7C). These observa-
tions are consistent with previous evidence that these viruses
exploit host peptide mimicry as a means of host immune eva-
sion (39, 60). We suggest that herpesviruses, which establish
persistent but nonprogressive infection in the vast majority of
human hosts, may evade the immune system (18) by exploiting
the “holes” in the T-cell repertoire that are created by negative
thymic selection. The similarity of herpesvirus and adenovirus
proteome sequences to self-peptides would also be anticipated
to induce more speciﬁc, less cross-reactive T-cell responses
(10, 18), which may contribute to the progressive inﬂation of
herpesvirus-speciﬁc T cells with a restricted T-cell receptor
(TCR) repertoire during human ageing (33).
HLA-B alleles target RNA viruses more efﬁciently. In con-
trast to results obtained for human protein and DNA viral
protein targeting by HLA class I, we found that HLA-B alleles
had higher efﬁciency scores for RNA viruses (Fig. 6B) (P 
10
16), with preferential targeting of evolutionarily conserved
viral proteins by HLA-B noted for 23/34 (68%) of RNA viruses
assessed (Table 1). Further scrutiny revealed a spectrum of
targeting efﬁciency proﬁles across the range of HLA-B-virus
pairs. At one end of the spectrum we found a general trend
toward positive HLA-B efﬁciency scores for the human-
adapted Paramyxoviridae (including respiratory viruses such as
respiratory syncytial virus, parainﬂuenza virus, and metapneu-
movirus, as well as measles and mumps viruses) and the Picor-
naviridae (predominantly rhinovirus and enterovirus species).
These RNA viruses exhibit a diverse range of “high-efﬁciency”
HLA-B speciﬁcities (Fig. 5), consistent with the existence of a
host-pathogen evolutionary relationship that is relatively spe-
ciﬁc for the HLA-B locus. Preferential and efﬁcient targeting
of these highly infectious, but nonpersistent, RNA viruses by
the highly polymorphic HLA-B locus could also provide a
potential mechanism for the observed rapid evolution of
these viral species, characterized by the emergence of tran-
sient viral mutations (which may provide an HLA context-
speciﬁc selection advantage) that are then purged by puri-
fying selection (22, 52).
At the other end of this spectrum, the arboviral Flaviviridae
are a dramatic counter-example to the general observation that
HLA molecules preferentially target evolutionarily conserved
proteomic regions. As shown in Fig. 5, most HLA-A and
HLA-B molecules preferentially targeted nonconserved pro-
tein sequences from arboviral ﬂaviviruses.
Comparing HLA efﬁciency proﬁles of pathogens provides
additional evidence for host pathogen coevolution. Targeting
efﬁciency scores for two different protein groups are often
correlated across different HLA alleles. For example, we found
a strong negative correlation between allele efﬁciency scores
for ﬂaviviruses and the efﬁciency scores for human proteins or
double-stranded DNA (dsDNA) viruses (Fig. 7A and C). The
ﬁnding that HLA-A and HLA-B alleles that target conserved
regions of human (self) proteins tend to target nonconserved
regions of the dengue virus suggests that these viruses seek to
reduce similarity to self-peptides to the extent that they are
ignored by the immune system (18), thereby exploiting positive
T-cell selection to their advantage. This evolutionary strategy
also focuses HLA binding on relatively nonconserved viral
proteome regions that are likely to have functional and
genomic plasticity. We also ﬁnd correlations between unre-
lated viruses (Fig. 7C), suggesting that these pathogens share
common strategies to evade HLA-restricted immune surveil-
lance. In contrast, negative correlations between unrelated vi-
FIG. 4. Allele efﬁciency scores for OMIM human proteins by HLA supertype groups. HLA efﬁciency scores of 95 HLA alleles grouped by
supertypes are shown for the a set of 4,761 human proteins that form the OMIM database. As can be seen, HLA-A alleles have higher efﬁciency
scores than HLA-B alleles, with the exception of the B58 supertype.
1314 HERTZ ET AL. J. VIROL.
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 ruses may indicate that these pathogens exploit the weaknesses
in the immune surveillance created by overadaptation of the
immune system to one virus or the other.
We found that these correlations cannot be explained by the
sequence (dis)similarities among viruses: when the same cor-
relation factors are computed for simulated HLA binding pref-
erences, they are not as strong as they are for the 95 HLA
alleles analyzed here, which cover true binding properties for
over 90% of the European population. This again suggests a
prominent role for HLA targeting efﬁciency in shaping HLA
and pathogen coevolution (Fig. 7B; see also the supplemental
material).
HLA-disease associations and targeting efﬁciency. The ﬁnd-
ings presented thus far point to coadaptive relationships be-
tween HLA allelic diversity and human viruses but do not
address the functional relevance of these observations. It is
apparent from these analyses that relationships between virus
species and host HLA diversity are highly speciﬁc, indicating
specialized roles for HLA loci and for HLA allelic variants
within these loci. We thus considered whether HLA targeting
efﬁciencies for a given pathogen (with subsequent possible
consequences for HLA-restricted immune responses) are as-
sociated with altered infectious disease outcomes. We focused
on the speciﬁc examples of HIV disease progression, HIV viral
load, and the incidence of dengue hemorrhagic fever (DHF).
HLA targeting efﬁciency and susceptibility to dengue hem-
orrhagic fever. Dengue hemorrhagic fever is a severe clinical
manifestation of a secondary dengue ﬂavivirus infection. Pre-
vious studies have suggested that the pathogenesis of this syn-
drome involves cross-reactive T-cell responses (15), which may
be enriched in the context of low-afﬁnity interactions between
HLA class I and conserved viral peptides (as described for
FIG. 5. Heat map distribution of allele efﬁciencies for human viruses and human proteins (x axis) by HLA supertype families (y axis). A matrix
of efﬁciency scores computed for each of the 95 HLA alleles studied for 52 human viruses and a set of human proteins. Each entry in this efﬁciency
matrix represents the efﬁciency score of a speciﬁc HLA allele (y axis) for a speciﬁc viral proteome. HLA alleles were grouped by supertypes, and
human viruses were grouped by viral families and by Baltimore classiﬁcation. Average efﬁciency scores over a large set of human proteins are
presented in the bar to the left of the matrix. Distinct patterns of targeting efﬁciency can be observed for both HLA alleles (grouped by supertype
or loci) and for different viral groups and families. UC, unclassiﬁed alleles that have not been assigned to supertypes; HSV-1, herpes simplex virus
type 1; EBV, Epstein-Barr virus; CMV, cytomegalovirus; KSHV, Kaposi’s sarcoma-associated herpesvirus; SARs-CoV, severe acute respiratory
syndrome coronavirus; HTLV-1, human T-cell leukemia virus type 1; ssRNA, single-stranded RNA; RT, reverse transcriptase.
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 dengue viruses in Fig. 5; see also Fig. S7 in the supplemental
material) (10, 18). In support of this model, we found that
HLA alleles known to be associated with susceptibility to den-
gue hemorrhagic fever (11) appeared to be less likely to target
evolutionarily conserved proteomic regions than alleles that
confer resistance to this disease (P  0.05) (Fig. 8).
Using protein-speciﬁc HLA targeting efﬁciency for predict-
ing HIV-1 viral load and HIV disease progression. We next
analyzed the effect of HLA targeting efﬁciency for speciﬁc
HIV-1 proteins on HIV-1 viral load in a study population of
191 HIV clade B-infected, treatment-naive individuals from
the Western Australian HIV cohort for whom viral loads
(plasma HIV RNA level) and full HLA typing were available
(43). We computed HLA targeting efﬁciency for each individ-
ual by averaging binding scores over each patient’s speciﬁc
HLA-A and HLA-B repertoire, thus approximating the aggre-
gate ability of patient-speciﬁc HLA alleles to differentiate be-
tween conserved and variable targets.
While the above analysis of viral targeting involved full pro-
teome targeting efﬁciencies (Fig. 5), the underlying analysis of
residue-speciﬁc binding and conservation scores calculated for
individual viral proteins and for speciﬁc HLA alleles allows for
a more focused exploration of the landscape of HLA-pathogen
interactions based on targeting of particular individual pro-
teins (see, for example, Fig. S4 to S6 in the supplemental
material). Analysis of protein targeting efﬁciencies has the
potential for broader use in the investigation of viral immunity
relevant to natural infection as well as vaccine design and
evaluation, particularly when indicators of functional immunity
are available, as is the case in HIV-1 infection.
While overall HLA allele efﬁciencies toward HIV proteins
correlated negatively (but not signiﬁcantly) with log viral load
(P  0.24), certain individual protein targeting efﬁciencies
showed signiﬁcant correlations with viral load. For example,
HLA-B locus efﬁciency in targeting Gag protein alone is more
strongly correlated with viral load (r  0.19; P  0.009),
consistent with experimental evidence that HLA-B-restricted
cytotoxic T lymphocyte (CTL) responses to Gag epitopes play
a signiﬁcant role in determining the natural history of HIV
infection (6, 35, 36, 54). We then analyzed the distribution of
HLA allele efﬁciency scores for HIV-1 Gag according to their
known associations with HIV progression (9, 19) and found
that protective HLA alleles tend to rank more highly in tar-
geting efﬁciency of conserved Gag proteomic regions (Fig. 9).
We also investigated the combined effect of efﬁciency scores
for individual proteins and HLA loci on log viral load using
multivariate regression. This analysis used the efﬁciency scores
of all nine HIV proteins, taking into account proteasomal
cleavage, and was performed on multiple test/train splits of the
data (see supplemental material). Here, we found that HIV
efﬁciencies alone account for 7.0% of the log viral load vari-
ance (P  3.67 	 10
4; correlation, 0.27), gender alone ex-
plains 7.0%, and the patient’s ethnic group alone shows no
signiﬁcant explanatory power. The HLA efﬁciencies and gen-
der combined explain 11.2% of log viral load variance. The
explanatory power of efﬁciency scores was not attributable to a
single HLA allele or HLA supertype effect nor to confounding
demographic effects such as gender and race (described in the
supplemental material).
Incorporating proteasomal cleavage, HLA binding, and evo-
lutionary conservation: presentation efﬁciency. HLA binding
is not the sole determinant of potential immune targets. The
processing of intracellular antigens relies on relatively mono-
morphic and evolutionarily conserved proteins to optimize
peptide cleavage prior to HLA binding (47), thus providing an
additional mechanism for ligand selection. We therefore ex-
amined the potential inﬂuence of proteasomal cleavage on
targeting efﬁciency by using the NetChop algorithm (46, 55).
We analyzed targeting efﬁciency across human proteins and
viral species using a restricted data set of peptides with a high
probability of appropriate C terminus cleavage. We found that
proteasomal cleavage restriction has indeed coevolved with
HLA binding, and cleavage is also directed toward conserved
targets. As shown in Fig. S7 in the supplemental material, the
distribution of HLA targeting efﬁciencies remained similar to
those identiﬁed in Fig. 5, indicating that relationships between
HLA binding preference and evolutionary conservation are
preserved among peptide targets that are selected via the an-
tigen-processing complex.
DISCUSSION
In this study, we have found that HLA class I molecules
preferentially sample conserved regions of human proteins and
many viral families, as initially hypothesized by Hughes and
Hughes (23). We uncovered a striking exception in the arbo-
viral Flaviviridae species, where HLA molecules preferentially
target nonconserved regions. This methodology provides a ca-
pacity to map the landscape of host-virus interactions from a
novel perspective and also allows for closer examination of
these effects at the viral protein level (see Fig. S4 to S6 in the
supplemental material), providing a platform for comparative
analyses of the complex coevolutionary relationships that exist
between viruses and their human hosts.
These ﬁndings also provide evidence for the evolution of
HLA class I locus and allelic specialization, suggesting a partial
FIG. 6. Comparison of efﬁciency scores of human and plant DNA
(A) viruses and human and plant RNA viruses (B) utilizing mixed
effects analysis. The P values are based on mixed effects analysis (see
supplemental material).
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 division of labor between the coinherited HLA-A and HLA-B
loci. While molecules encoded in both loci participate in sur-
veillance of various proteins, the HLA-A locus and certain
HLA-B alleles appear to have a particularly important role in
surveillance of evolutionarily conserved regions of the human
proteome (14). This ﬁnding is speciﬁc to human (rather than
randomly selected) proteins and is even more evident at sites
of disease-associated mutation, suggesting optimization of li-
gand selection through human (and ancestral vertebrate) evo-
lution.
Further evidence of partial HLA specialization can also be
found through analyses of HLA-viral interactions as HLA al-
leles that target conserved elements from the human protein
repertoire also target conserved regions of human-adapted
DNA viruses. In this respect, our ﬁndings are supported by
other studies (18, 39, 60) indicating that these ancient DNA
viruses exploit holes in the repertoire of reactive T cells cre-
ated through thymic selection, thereby evading effective im-
mune surveillance by maintaining similarity to self-peptides.
We extend these observations to show that the extent to which
individual HLA alleles are adapted to bind conserved human
protein elements is highly correlated with their targeting efﬁ-
ciencies toward DNA viruses. We also ﬁnd that HLA-B alleles
tend to more efﬁciently target conserved regions of RNA vi-
ruses. These results are in keeping with those of Prugnolle et
al., who noted that relationships between pathogen diversity
TABLE 1. Comparison of HLA-A and HLA-B allele efﬁciencies
for 52 viruses
a
TABLE 1—Continued
a Results are color coded as follows: blue denotes viruses in which the efﬁ-
ciency score of HLA-A alleles is higher than the efﬁciency of HLA-B alleles, red
denotes cases where HLA-B alleles have higher efﬁciency scores, darker shades
represent differences which were found to be statistically signiﬁcant (P  0.05)
using a mixed-effects analysis, and lighter shades denote nonsigniﬁcant
differences.
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 and balancing selection are particularly evident at the HLA-B
locus (51). They are also supported by the ﬁndings of McAdam
et al. (41) and by Hughes et al. (24), who found that a large
number of HLA-B alleles are products of small-scale recom-
bination events and that the HLA-B locus evolves much more
rapidly than the HLA-A locus, suggesting that these two loci
have been subject to different types of natural selection over
long periods of time in response to different pathogenic
threats. Our results are also in line with evidence of more
effective HLA context-speciﬁc purifying selection followed by
reversion in RNA viruses than in DNA viruses, as reported by
Hughes et al. (22).
It is important to emphasize that these preferences exhibited
by HLA alleles are not evident when either HLA binding
energies or evolutionary conservation of target peptides is con-
sidered in isolation but only when these factors are considered
together. This is in keeping with the ﬁndings of Istrail et al.
(30), who conducted genome-wide analyses of binding prefer-
ences of HLA supertypes and found no meaningful differences
in the tendency of HLA alleles to bind human proteins over
proteins from other organisms.
Viewed from the perspective of viral evolution, these data
suggest that viral species choose distinct adaptive pathways
under HLA-restricted immune selection (1, 40). This is most
dramatically illustrated for the arboviral Flaviviridae species, in
which variable rather than conserved proteomic regions are
the preferred targets for HLA binding. Evolution toward the
“extinction” of predicted HLA targets in the dengue virus
genome has been noted previously (21). In this context, it is
interesting that dengue virus infection actively promotes
(rather than downregulates) TAP (transporter associated with
antigen processing)-dependent antigen processing and HLA
class I cell surface expression during ﬂavivirus infection (20),
indicating that the ﬂaviviruses employ immune evasion strate-
gies that are the opposite of those of many DNA viral species.
This particular adaptive strategy may be inﬂuenced by the
fact that arboviral ﬂaviviruses must maintain the ability to
infect arthropod vectors as well as vertebrate hosts (includ-
ing nonhuman primates) without signiﬁcant genomic adap-
tation (37, 59).
The HLA targeting efﬁciency scores may also prove a useful
tool for predicting patient response to infections, as illustrated
by the examples of disease outcomes in dengue virus and
HIV-1 infections. These scores provide an example of a novel,
numeric, and real-valued representation of an HLA molecule,
which can be utilized to quantify similarities and differences
between HLA molecules based on a target preference func-
tion. Such a projection allows identiﬁcation of common target-
FIG. 7. Correlations between allele efﬁciency scores for human proteins and human viruses. (A) Correlation (Spearman rank) between allele
efﬁciency scores for human proteins, cytomegalovirus (herpesvirus), and dengue virus (ﬂavivirus) (each representing one column in Fig. 5).
(B) Frequency distributions of correlation coefﬁcients between proteomes derived from randomized HLA alleles (n  10,000) compared with
actual values from panel A, as indicated with arrows. (C) Correlation matrix of efﬁciency scores: human and viral proteomes (the three scores from
panel A are dots with appropriate intensity in this matrix). The extent to which HLA efﬁciency scores are correlated between human viruses, as
well as self-peptides (extreme left column), is represented here according to Spearman rank correlation coefﬁcient values. For abbreviations, see
the legend of Fig. 5.
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 ing characteristics among patients with different HLA types,
thus potentially increasing statistical power in the analysis of
patient cohorts. This representation is similar in concept to
HLA supertypes (56), which was previously the only method
for classifying HLA alleles while attempting to retain biologi-
cally meaningful differences. Further studies will be required to
investigate these attributes, but it is notable that relationships
between HLA targeting efﬁciency and HLA supertype classi-
ﬁcations are by no means uniform, as evidenced in the HIV
viral load analysis as well as in the data shown in Fig. 4 and 5
and in Fig. S4 in the supplemental material.
However, multiple factors contribute to disease expression
in the context of viral infection, and HLA class I binding is only
one of many necessary but not sufﬁcient, genetically deter-
mined factors involved in antigen processing and the subse-
quent generation of pathogen-speciﬁc immune responses. To
investigate the potential inﬂuence of one of these factors, we
examined the effect of proteasomal cleavage on HLA targeting
efﬁciency. We found that proteasomal cleavage restriction was
also directed toward conserved targets (see Fig. S7) but that
the tendency of HLA alleles to target conserved regions re-
mained as strong even when only the peptides which were
likely cleavage targets were considered. This suggests that both
HLA-peptide binding and proteasomal cleavage have been
co-optimized to target conserved regions.
Previous studies of HLA allele-speciﬁc viral polymorphisms
(27–29, 60, 63) have shown that adaptive interactions between
individual human hosts and autologous viral populations are
unique and highly dynamic, involving the evolution of HLA-
speciﬁc CTL escape mutations that are known to inﬂuence the
natural history of viral infection (43). We therefore offer that
the methods described here, designed to investigate the broad
patterns of host-pathogen coevolution across multiple viruses,
complement other approaches that examine one virus at a
time, such as studies that reveal host-virus adaptation by as-
sessing HLA-associated viral polymorphisms (27, 60, 63) or
phylogeny (28, 29).
Our analyses using a diverse array of HLA alleles and viral
proteomes suggest that, in general, HLA-A preferentially tar-
gets DNA viruses and that HLA-B preferentially targets RNA
viruses while both HLA-A and -B alleles tend to bind to non-
conserved regions in arboviral ﬂaviruses. It must be empha-
sized that these broad observations identify trends and will not
generalize to all the viruses and the individual proteins or
epitopes within those viruses.
Although viruses typically encode thousands of amino acids,
most of the responding CD4
 and CD8
 T cells recognize a
tiny fraction of the potential antigenic determinants (65). This
serves to maximize the efﬁciency of clonal recruitment and
activation for a highly speciﬁc and avid antiviral response.
More than 90% of CD8 T-cell immunodominance is thought
to be explained by HLA-peptide binding afﬁnity, as only 1%
of peptides form a complex with HLA class I molecules with
sufﬁcient stability to be presented in adequate numbers to
activate naïve CD8
 T cells (65). While within-host immu-
nodominance may underpin efﬁcient primary and secondary
responses to some acute viral infections, the extreme domi-
nance of a few or even single clonotypes associated with some
persistent viruses and vaccine-induced responses is problem-
atic if those immunodominant responses are not protective.
The study of targeting efﬁciency in such infections may help
clarify, in part, virus-speciﬁc immunodominance patterns and
the strategies different groups of viruses have taken to coun-
teract these. This has signiﬁcant implications for vaccine im-
munogen design as the efﬁcacy of an immunodominant vac-
cine-induced response is likely to be improved if directed
against determinants that have high targeting efﬁciency and are
FIG. 8. Targeting efﬁciencies for dengue virus (serotype 2, whole
proteome), for all 95 analyzed HLA alleles. Each dot marks the efﬁ-
ciency score of a single HLA allele. Alleles are sorted by loci. Blue bars
represent average locus efﬁciencies. HLA alleles previously associated
with hemorrhagic fever are marked by squares, and those associated
with protection are indicated with diamonds. Differences between the
two groups were found to be signiﬁcant (P  0.05).
FIG. 9. Targeting efﬁciencies for HIV-1 Gag protein for all 95
analyzed HLA alleles. Each dot marks the efﬁciency score of a single
HLA allele. Alleles are sorted by loci. Blue bars represent average loci
efﬁciencies. HLA alleles previously associated with slow HIV disease
progression are marked by triangles, and those associated with rapid
disease progression are indicated with squares. Alleles that have been
associated with protection from infection are marked by diamonds.
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 functionally important to the virus rather than determinants
that reproduce the counter-evolutionary strategies of the virus.
In conclusion, this study has taken advantage of recent ad-
vances in large-scale genome sequencing, HLA binding mea-
surements, and curation, along with the availability of compu-
tationally intensive analysis techniques, to address the
hypothesis that HLA class I-restricted peptide sampling is
preferentially targeted to evolutionarily conserved, function-
ally important regions of human and viral proteomes. The data
support this view and also provide support for balancing selec-
tion of HLA class I allelic diversity (particularly at the HLA-B
locus) anchored on this property in response to the challenges
provided by diverse human viruses. The approach provides a
novel perspective on the ongoing coevolutionary relationships
between HLA class I polymorphism, adaptive T-cell immunity,
and the self-peptides and viruses that engage with these sys-
tems.
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